Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Gastrointestinal, Thoracical or Urogenital Cancer Surgery.
N/A
65 Years
N/A
65 Years
N/A
Open (Enrolling)
Both
Cancer
Both
Cancer
Trial Information
Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Gastrointestinal, Thoracical or Urogenital Cancer Surgery.
Inclusion Criteria:
- Patients aged 65 years and older with abdominal, thoracical or urogenital cancer
scheduled for surgery
- Offered patient information and written informed consent
- Confirmed cancer diagnosis via histology
- Mini Mental state > 23
- Life-expectance > 2 months
Exclusion Criteria:
- Participation in another trial according to the German Drug Law 7 days to and 7 days
after the operation during the study
- No informed consent
- Emergency patients
- Lacking willingness to save and hand out data within the study
- Accommodation in an institution due to an official or judicial order
- Concurrent malignancies
- Insufficient knowledge of the German language
- In case of the inclusion of a PERATECS - study patient in an adjuvant therapy study
during the study period, the patient will be excluded from the PERATECS-study
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
Length of hospital stay
Outcome Time Frame:
within the first month
Safety Issue:
No
Principal Investigator
Claudia Spies, MD Prof.
Investigator Role:
Study Chair
Investigator Affiliation:
Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin
Authority:
Germany: Ethics Commission
Study ID:
PERATECS
NCT ID:
NCT01278537
Start Date:
February 2011
Completion Date:
February 2014
Related Keywords:
- Cancer
- elderly
- cancer surgery
- quality of life
- empowerment
- shared-decision
Name | Location |
|---|
